AI assistant
Q32 Bio Inc. — Director's Dealing 2023
Nov 17, 2023
34891_dirs_2023-11-17_e7fc3994-1c40-47b0-82e0-01e39d6cda03.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2023-11-17
Reporting Person: Michaud Charles Jr (See Remarks)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2112 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $15.58 | 2030-07-08 | Common Stock (25000) | Direct | |
| Employee Stock Option (Right to Buy) | $13.91 | 2031-02-16 | Common Stock (9800) | Direct | |
| Employee Stock Option (Right to Buy) | $2.71 | 2032-02-24 | Common Stock (19300) | Direct | |
| Employee Stock Option (Right to Buy) | $1.60 | 2033-02-23 | Common Stock (49000) | Direct | |
| Restricted Stock Units | $ | Common Stock (544) | Direct | ||
| Restricted Stock Units | $ | Common Stock (2144) | Direct | ||
| Restricted Stock Units | $ | Common Stock (8000) | Direct |
Footnotes
F1: The option vests or has vested as to 25% of the underlying shares on June 8, 2021 and in 36 substantially equal monthly installments upon the Reporting Person's completion of each full month of service thereafter so that such option will become fully vested on June 8, 2024.
F2: The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2021 such that the option will become fully vested on January 1, 2025.
F3: The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2022 so that such option will become fully vested on January 1, 2026.
F4: The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023 so that such option will become fully vested on January 1, 2027.
F5: The restricted stock units will vest and settle in full on January 1, 2024.
F6: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
F7: The restricted stock units will vest and settle as to 1,056 shares on January 1, 2024 and 1,088 shares on January 1, 2025.
F8: The restricted stock units will vest and settle as to one-third of the restricted stock units on each of the first three anniversaries of January 1, 2023.